Related Experiment Video
Updated: Jan 31, 2026

Author Spotlight: Quantifying Siderophores and Pyochelin for Infection Control
Published on: March 15, 2024
Multidrug Resistant Pseudomonas aeruginosa in Iran: A Systematic Review and Metaanalysis
Hamid Vaez1, Amin Salehi-Abargouei2,3, Zahra Rashki Ghalehnoo1
1Department of Microbiology, School of Medicine, Zabol University of Medical Sciences, Zabol, Iran.
Background:
Multidrug-resistant Pseudomonas aeruginosa (MDR P. aeruginosa) is known as a serious threat to human health worldwide. Limited information is available concerning the prevalence of MDR P. aeruginosa in Iran. The aim of the present study was to investigate the relative frequency of MDR P. aeruginosa in different parts of Iran.
Materials And Methods:
Using appropriate keywords and well-known English and Persian database, available data about MDR P. aeruginosa in Iran were retrieved. After applying predefined criteria, relevant studies were selected.
Results:
By using random-effect models, the pooled incidence of MDR P. aeruginosa was estimated 58% (95% confidence interval [CI]; 0.54-0.61). The highest and lowest prevalence of MDR P. aeruginosa were observed in Tehran (100%) (95% CI; 0.94-1.00) and Zahedan (16%) (95% CI; 0.10-0.24), respectively. The highest resistance rate was against ceftazidime (50%) (95% CI; 0.46-0.54) and amikacin (50%) (95% CI; 0.46-0.54).
Conclusion:
Our findings are of concern since they demonstrate the high prevalence rate of MDR P. aeruginosa in the majority of Iranian hospitals.
Insights
Multidrug-resistant Pseudomonas aeruginosa (MDR P. aeruginosa) is a significant global health concern. This study reveals a high prevalence of MDR P. aeruginosa in Iranian hospitals, with an overall estimated incidence of 58%.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Public Health
Background:
- Multidrug-resistant Pseudomonas aeruginosa (MDR P. aeruginosa) poses a substantial global health threat.
- There is a lack of comprehensive data on MDR P. aeruginosa prevalence in Iran.
- This study addresses the knowledge gap regarding the geographic distribution of MDR P. aeruginosa in Iran.
Purpose of the Study:
- To determine the prevalence of MDR P. aeruginosa across various regions of Iran.
- To provide an updated epidemiological overview of MDR P. aeruginosa in the Iranian context.
Main Methods:
- A systematic literature search was conducted using Persian and English databases.
- Relevant studies on MDR P. aeruginosa in Iran were identified and selected based on predefined inclusion criteria.
Main Results:
- The pooled incidence of MDR P. aeruginosa in Iran was estimated at 58% (95% CI: 0.54-0.61).
- Prevalence varied significantly by region, with Tehran reporting 100% and Zahedan 16%.
- High resistance rates were observed against ceftazidime and amikacin (both 50%).
Conclusions:
- The findings indicate a concerningly high prevalence of MDR P. aeruginosa in many Iranian hospitals.
- These results underscore the urgent need for enhanced infection control strategies and antimicrobial stewardship programs in Iran.
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Random and Systematic Errors
Directing Effect of Substituents: meta-Directing Groups
Systematic Sampling Method
Systematic sampling is one of the simplest methods...
Propagation of Uncertainty from Systematic Error

